New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer: Clinical and Shared Decision Making Implications for the Oncology Nurse
At-A-Glance: Nursing Considerations for Adjuvant Treatment Approaches for Patients With HER2+ Early Breast Cancer
Redefining Triple-Negative Breast Cancer: Understanding the Clinical Evidence That Will Transform Practice
Highlights From the 2017 ESMO Congress
Biosimilars in the Evolving Cancer Care Landscape: Experts Address Current Questions, Controversies, and Impact on Clinical Practice
Conference CoverageEducationClinicalThoughtDecision SupportCCO Live EventsSlidesets & Resources
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
Clinical Care Options, LLC. All Rights Reserved.